These metabolic modifications not only support cancer cells to survive but also interact with oncogenic signaling pathways, such as phosphoinositide 3-kinase/protein kinase B- (PI3K/Akt), Myc-, Ras-, p53-, and reactive oxygen species- (ROS-) related pathways. Here, AKT1 is linked to cancer.